ACXP (STOCKS)
Acurx Pharmaceuticals, Inc. Common Stock
$1.570000
+0.000000 (+0.00%)
Prev close: $1.570000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David P. Luci
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6.77M
- Employees
- 4
- P/E (TTM)
- -0.36
- P/B (TTM)
- 0.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $7.63M |
| Research and Development | $1.58M |
| Other Operating Expenses | $6.05M |
| Operating Income/Loss | -$7.63M |
| Income/Loss From Continuing Operations After Tax | -$7.50M |
| Income/Loss From Continuing Operations Before Tax | -$7.50M |
| Net Income/Loss | -$7.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.50M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.05 |
| Diluted Earnings Per Share | -$4.05 |
| Basic Average Shares | 5,757,705 |
| Diluted Average Shares | 5,757,705 |
| Assets | $9.54M |
| Current Assets | $9.54M |
| Prepaid Expenses | $228.83K |
| Other Current Assets | $9.31M |
| Noncurrent Assets | $0.00 |
| Liabilities | $2.53M |
| Current Liabilities | $2.53M |
| Wages | $24.67K |
| Other Current Liabilities | $2.50M |
| Noncurrent Liabilities | $0.00 |
| Equity | $7.01M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.01M |
| Liabilities And Equity | $9.54M |
| Net Cash Flow From Operating Activities | -$6.14M |
| Net Cash Flow From Operating Activities, Continuing | -$6.14M |
| Net Cash Flow From Investing Activities | -$4.61M |
| Net Cash Flow From Investing Activities, Continuing | -$4.61M |
| Net Cash Flow From Financing Activities | $10.75M |
| Net Cash Flow From Financing Activities, Continuing | $10.75M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$7.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.50M |
| Other Comprehensive Income/Loss | $0.00 |